Nutritional supplements and extracts like Beta-sitosterol have benefits and are used by cancer patients and those at-genetic risk of cancer. There is limited or hardly any clinical data available for use of nutritional supplements and foods in cancer patients. Generating clinical evidence of efficacy for cancer through a randomized clinical trial is further infeasible due to variations in genetics and cancer chemotherapy treatments across cancer patients. Hence a different and new approach is needed to find out for which cancers you should not take Beta-sitosterol supplement and why should not take them?
Is it okay to take Beta-sitosterol extracts or supplements for all cancer indications and any chemotherapy treatment? A common belief but a myth is that everything natural can only be of benefit and do no harm. For example, the use of grapefruit with certain medications is not recommended. Another example is the use of spinach with some blood thinning medications can cause adverse interactions and hence to be avoided. For cancer, nutrition including plant-based foods and supplements can influence outcomes and hence an extremely important decision which needs to be made. Hence NIH-National Cancer Institute has a website for nutrition for cancer care for patients which are generalized recommendations and not personalized for cancer indication and treatments.
A frequently asked question by cancer patients and those at-risk is “What Foods and Nutritional Supplements could be beneficial over others for me?”. “Who should not take an extract or supplement and why?”. Generic guidelines like eating only plant-based-foods or avoiding all sugar or adopting a keto diet is a good start but not actionable and personalized enough.
To find answers to questions on extracts and nutritional supplements and foods requires knowledge of contained active ingredients; genetic mutation prevalence for cancer indication; understanding of underlying cancer biology; chemotherapy treatments and mechanism of actions of active ingredients.
Taking Beta-sitosterol extracts or nutritional supplements may benefit Primary Penile Squamous Cell Carcinoma patients on Cisplatin treatment over Broccoli nutritional supplements. But Beta-sitosterol supplements or Beta-sitosterol extracts offer less benefit if on Nelarabine treatment for Primary Early T Cell Precursor Acute Lymphoblastic Leukemia compared to Horseradish. Similarly, taking nutritional supplements Beta-sitosterol may benefit healthy individuals who are at genetic risk of cancer due to mutation of gene MLH1 over Lemon. But avoid nutritional supplements Beta-sitosterol when at genetic risk of cancer due to mutation of gene.
The takeaway being – cancer, genomics, treatments and other personalized factors will influence decision making to questions like: Are extracts or nutritional supplements Beta-sitosterol beneficial and should not be taken? Why should Beta-sitosterol be not taken? Who should not take Beta-sitosterol? What are side effects of Beta-sitosterol with Nelarabine chemotherapy? What are the benefits of Beta-sitosterol for cancer? Can Beta-sitosterol help fight cancer and so on.
Whenever there are changes in chemotherapy treatments or cancer tissue genetics – the nutrition may change and hence needs to be re-evaluated. Do consider factors like cancer indication, ongoing chemotherapy treatments and nutritional supplements, age, gender, weight, height, lifestyle and genetics for personalization of nutrition.
Use of nutritional supplements – vitamins, herbs, minerals, probiotics, and other specialty categories are increasing. Supplements are high concentrations of active ingredients which are also found in different foods. Difference between supplements and foods being that foods contain more than one active ingredient at much lower concentrations. Every active ingredient in an extract or nutritional supplement or food has a unique mechanism of action which can influence nutrition decisions.
These are some example questions which nutrition planning should help answer for you. Should you take supplements Beta-sitosterol? Should you take it when at genetic risk of cancer for mutation of gene MLH1? Should you take it when at genetic risk of cancer for mutation of gene? Should you take it when diagnosed with Primary Early T Cell Precursor Acute Lymphoblastic Leukemia? Should you take it when diagnosed with Primary Penile Squamous Cell Carcinoma? Should you take it when on Cisplatin treatment? Should you continue taking it if you change your treatment from Cisplatin to Nelarabine? So a general explanation like – it is organic and plant-based or it increases immunity is not sufficient information for making a decision of use of Beta-sitosterol extracts and nutritional supplements.
Genetic variations across cancer patients can be different and hence no two cancers are alike. The improved availability of “personalized to genetics” chemotherapy treatments and cancer disease monitoring via blood and saliva have been significant factors to improve outcomes. The earlier the lifestyle and treatment intervention – the better the influence on outcome. Genetic testing has the potential to assess cancer risk and susceptibility early. But for at-risk individuals besides regular monitoring in most cases there are no therapeutic treatment intervention options available. After diagnosis with cancer such as Primary Penile Squamous Cell Carcinoma or Primary Early T Cell Precursor Acute Lymphoblastic Leukemia, the treatments get personalized to tumor genomics and factors like staging of disease, age and gender. During cancer remission (after treatment cycle is complete) – monitoring is used for assessment of any relapse and accordingly decide on next steps. A large majority of cancer patients and those at-risk may take nutritional supplements like Beta-sitosterol.
So the question is that are all genetic risks and cancer indications to be considered uniformly when making decisions on the use of Beta-sitosterol extracts or nutritional supplements? Are the biochemical pathway implications of genetic risk for cancer due to mutation of gene MLH1 the same as due to mutation of gene? Are the implications of Primary Penile Squamous Cell Carcinoma the same as Primary Early T Cell Precursor Acute Lymphoblastic Leukemia? Is it one and the same if you are on treatment with Nelarabine or Cisplatin?
Beta-sitosterol – An Extract or Nutritional Supplement
Beta-sitosterol is a phytosterol (plant sterol) with structure similar to cholesterol. It is found in various dietary and non-dietary plants. It is considered to have medicinal properties including antidiabetic, hypolipidemic, neuroprotective and chemopreventive or anti-cancer effects. (Shyamaladevi Babu and Selvaraj Jayaraman, Biomed Pharmacother., 2020)
Beta-sitosterol supplements contain many active ingredients including Beta-sitosterol at different concentration levels. The molecular pathways which are regulated by Beta-sitosterol include P53 Signaling, Oncogenic Cancer Epigenetics and Epithelial to Mesenchymal Transition. These biochemical pathways directly or indirectly regulate specific cancer molecular endpoints like growth, spread and death of cancer cells. Because of this biological regulation – for cancer nutrition, the right choice of supplements like Beta-sitosterol individually or in combination is an important decision to be made. When making decisions on the use of supplement Beta-sitosterol over other nutritional supplements – do consider all these factors.
Who Should not take Beta-sitosterol Supplements and Why?
There is no easy way to answer the question “For which cancers should I not chooseBeta-sitosterol nutritional supplements”. Just like the same chemotherapy treatment does not work across patients, for similar reasons Beta-sitosterol in comparison with other nutritional supplements may be beneficial or not. Along with which cancer and associated genetics – the ongoing treatments, lifestyle habits, height, weight and food allergies are all factors in deciding if Beta-sitosterol should be avoided or not and why.
1. Will Beta-sitosterol Supplements benefit Primary Early T Cell Precursor Acute Lymphoblastic Leukemia patients undergoing Nelarabine treatment?
Primary Early T Cell Precursor Acute Lymphoblastic Leukemia is characterized and driven by specific genetic mutations like NOTCH1, JAK1 and SCNN1B leading to biochemical pathway changes in Oncogenic Cancer Epigenetics, Notch Signaling, RUNX Signaling, Hematopoiesis, Interferon Signaling and Small Molecule Transport. A cancer treatment like Nelarabine works through a specific pathway mechanism of action. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach which is effective. In such a condition any food or nutritional supplement which has a contrary effect to the treatment or reduces the overlap should be avoided. As an example, Beta-sitosterol supplement should not be taken for Primary Early T Cell Precursor Acute Lymphoblastic Leukemia along with treatment Nelarabine. Beta-sitosterol supplement impacts the biochemical pathway called Oncogenic Cancer Epigenetics which either promotes drivers of the disease and/or nullifies the treatment effect. Some of the factors which should be considered when choosing nutrition are type of cancer, treatments and supplements being taken currently (if any
2. Will Beta-sitosterol Supplements benefit Primary Penile Squamous Cell Carcinoma Patients undergoing Cisplatin Treatment?
Primary Penile Squamous Cell Carcinoma is characterized and driven by specific genetic mutations like ABRAXAS1, PIK3CB and NUP93 leading to biochemical pathway changes in P53 Signaling, Hematopoiesis and Inositol Phosphate Signaling. A cancer treatment like Cisplatin works through specific pathway mechanisms. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach. In such a condition any food or nutritional supplement which supports treatment action or improves the overlap should be considered. As an example, Beta-sitosterol supplements should be considered for Primary Penile Squamous Cell Carcinoma along with the treatment Cisplatin. Beta-sitosterol supplement impacts pathways/processes like P53 Signaling which either obstruct drivers of Primary Penile Squamous Cell Carcinoma and/or improve Cisplatin treatment effect.
Foods to Eat After Cancer Diagnosis!
No two cancers are the same. Go beyond the common nutrition guidelines for everyone and make personalized decisions about food and supplements with confidence.
3. What about Beta-sitosterol Supplements for Healthy Individuals with MLH1 Mutation associated Genetic Risk?
MLH1 is one of the genes available in panels for cancer risk testing. MLH1 mutation causes biochemical pathways/processes like Epithelial to Mesenchymal Transition and Mismatch Repair to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Beta-sitosterol supplements may be considered when the genetic panel identifies mutations in MLH1 for Colon Cancer. Beta-sitosterol impacts pathways/processes like Epithelial to Mesenchymal Transition and creates a canceling effect in those individuals with MLH1 mutation.
* Other Factors are also included like BMI, Treatments, Lifestyle Habits
It is important to remember that cancer chemotherapy treatments and nutrition are never the same for everyone. Food and nutritional supplements like Beta-sitosterol are chosen by you and can influence outcomes.
“What should I eat?” is a commonly asked question by cancer patients and those at-risk. The answer to this question depends on cancer indication, underlying genetics, current chemotherapy treatments, food allergies, lifestyle information, and food preferences.
The addon.life approach to nutrition personalization uses knowledge of active ingredients contained in foods and nutritional supplements, cancer biology, chemotherapy treatment action and genetic mutation prevalence across cancer indications. addon.life team of clinicians, clinical scientists and engineers are experts in cancer biology focusing only on nutrition personalization for cancer patients and those at-risk.
What food you eat and which supplements you take is a decision you make. Your decision should include consideration of the cancer gene mutations, which cancer, ongoing treatments and supplements, any allergies, lifestyle information, weight, height and habits.
The nutrition planning for cancer from addon is not based on internet searches. It automates the decision making for you based on molecular science implemented by our scientists and software engineers. Irrespective of whether you care to understand the underlying biochemical molecular pathways or not - for nutrition planning for cancer that understanding is needed.
Get started NOW with your nutrition planning by answering questions on the name of cancer, genetic mutations, ongoing treatments and supplements, any allergies, habits, lifestyle, age group and gender.
- β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial-Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling.
- Paederia foetida induces anticancer activity by modulating chromatin modification enzymes and altering pro-inflammatory cytokine gene expression in human prostate cancer cells.
- Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors.
- cBioPortal for Cancer Genomics
- Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.
- [A test for determining personality traits in patients with organic psychosomatic diseases].
- PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia.
- cBioPortal for Cancer Genomics
- Cancer therapy shapes the fitness landscape of clonal hematopoiesis.
Personalized Nutrition for Cancer!
Cancer changes with time. Customize and modify your nutrition based on cancer indication, treatments, lifestyle, food preferences, allergies and other factors.